Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
16.1M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
194K
-
Shares change
-
+194K
-
Total reported value, excl. options
-
$103K
-
Value change
-
+$103K
-
Number of buys
-
4
-
Price
-
$0.53
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA) as of Q2 2025
4 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share as of Q2 2025.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 194K shares
of 16.1M outstanding shares and own 1.2% of the company stock.
Largest 4 shareholders include MARSHALL WACE, LLP (124K shares), BECK MACK & OLIVER LLC (70K shares), EverSource Wealth Advisors, LLC (49 shares), and SBI Securities Co., Ltd. (2 shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.